Start Date
Not specified
Mino-Lok Therapy (MLT)
Standard of Care antibiotics appropriate for the infecting organism plus Mino-Lok therapy to disinfect and save the catheter. Mino-Lok is made available through this expanded access protocol to patients who otherwise do not qualify for the phase 3 clinical trial (NCT02901717) Other Name: Standard of care antibiotics + Mino-Lok
AVAILABLE
Georgetown University Hospital, Washington D.C.
AVAILABLE
Anne Arundel Medical Center, Annapolis
AVAILABLE
Salem VA Medical Center, Salem
AVAILABLE
East Carolina University, Greenville
AVAILABLE
Carolinas Medical Center, Charlotte
AVAILABLE
University of Florida - Shands Hospital - Dialysis Center, Gainesville
AVAILABLE
University of Kentucky Medical Center, Lexington
AVAILABLE
University Hospitals Cleveland Medical Center, Cleveland
AVAILABLE
Cleveland Clinic, Cleveland
AVAILABLE
University of Cincinnati, Cincinnati
AVAILABLE
Indiana Blood and Marrow Institute, Indianapolis
AVAILABLE
William Beaumont Hospital, Troy
AVAILABLE
Harper University Hospital, Detroit
AVAILABLE
Henry Ford Health Systems, Detroit
AVAILABLE
AMG Oncology, Park Ridge
AVAILABLE
Lutheran Hospital, Park Ridge
AVAILABLE
Edward Hines Jr. VA Hospital, Hines
AVAILABLE
Ascension Via Christi Hospital, Wichita
AVAILABLE
University of Texas MD Anderson Cancer Center, Houston
AVAILABLE
Phoenix VA Health Care System, Phoenix
AVAILABLE
University of New Mexico, Albuquerque
AVAILABLE
VA Sierra Nevada Health Care Systems, Reno
AVAILABLE
Seattle Children's Hospital, Seattle
AVAILABLE
Yale University School of Medicine, New Haven
AVAILABLE
Massachusetts General Hospital, Boston
AVAILABLE
St. Vincent Hospital, Worcester
AVAILABLE
Saint Michael's Medical Center, Newark
AVAILABLE
VA Caribbean Healthcare System, San Juan
AVAILABLE
Manati Medical Center, Manatí
AVAILABLE
Ponce Research Institute, Ponce
Lead Sponsor
Leonard-Meron Biosciences, Inc.
INDUSTRY